| | First author | Year | Study design | Sample size | Inclusion criteria | Initial circumferential RFA regimen | Surveillance focal RFA regimen and other endoscopic modalities | Previous ER (%) | Follow-up regimen | Follow-up, mean or median (IQR) (m) |
| | Pouw [44] | 2008 | Case report | 1 | HGIN/ESCC | J/cm2+cleaning | No | No | D3, M2, M4 | 4 | | Becker [38] | 2011 | Case series | 6 | ESCC | J/cm2 | J/cm2 | Yes (67%) | M1, M3, M6, and biannually thereafter | 10.5 (10-13) | | Vilsteren [34] | 2011 | Prospective case series | 13 | HGIN/ESCC | J/cm2+cleaning ( J/cm2 in 6 cases) | J/cm2+cleaning between each two† | Yes (69%) | M3, M6, and annually thereafter | 17 (11-22) | | Bergman [35] | 2011 | Prospective cohort | 29 | MGIN/HGIN/ESCC | J/cm2 or J/cm2±cleaning | J/cm2 | No | M3, M6, M9, and M12 | 12 | | Haidry [41] | 2013 | Prospective cohort | 20 | HGIN/ESCC | J/cm2 | J/cm2 | Yes (25%) | M3, M6, M9, and M12 | 24 (17-54) | | Wang [45] | 2014 | Prospective case series | 7 | HGIN/ESCC | J/cm2+cleaning | J/cm2+APC | No | M1, M3, M6, and biannually thereafter | 10.5 | | Wang [8] | 2015 | Retrospective cohort | 18 | HGIN/ESCC | J/cm2+cleaning | J/cm2+APC | No | M1, M3, M6, and biannually thereafter | 13.1 | | He [39] | 2015 | Prospective cohort | 96 | MGIN/HGIN/ESCC | J/cm2 or J/cm2 or J/cm2±cleaning | 3 × 12 J/cm2 | No | M3, M6, M9 and M12 | 12 | | Wang [46] | 2016 | Prospective cohort | 30 | HGIN/ESCC | J/cm2+cleaning | J/cm2+APC | No | M1, M3, M6, and biannually thereafter | 17 | | Wang [43] | 2017 | Retrospective cohort | 8 | HGIN/ESCC | J/cm2±cleaning | J/cm2+APC | No | M1, M3, M6, and biannually thereafter | 21.6 | | Wang [26] | 2018 | Prospective cohort | 35 | HGIN/ESCC | J/cm2+cleaning | J/cm2 | No | M1, M3, M6, and biannually thereafter | 40.1 (24-66) | | Yu [40] | 2019 | Prospective cohort | 78 | MGIN/HGIN/ESCC | J/cm2 or J/cm2 or J/cm2±cleaning | J/cm2 | No | M3, M6, M9, M12, and every 3 months or annually thereafter | 60 |
|
|
